Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-25-002037
Filing Date
2025-01-08
Accepted
2025-01-08 16:21:56
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 tm251946-4_424b5.htm 424B5 626559
2 EX-FILING FEES tm251946d5_ex-filingfees.htm EX-FILING FEES 18242
3 GRAPHIC lg_uniqure-4c.jpg GRAPHIC 27300
  Complete submission text file 0001104659-25-002037.txt   683581
Mailing Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP
Business Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP 1-339-970-7000
uniQure N.V. (Filer) CIK: 0001590560 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-284168 | Film No.: 25518790
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)